FDG PET/CT in Immuno-Oncology

Area of Science:

• Oncology
• Nuclear Medicine
• Immunology

Background:

• 18F-fluorodeoxyglucose PET-CT (FDG PET/CT) is the standard for cancer metabolic imaging.
• It plays a key role in managing patients undergoing immunotherapy.

Purpose of the Study:

• To examine the diverse applications of FDG PET/CT in immuno-oncology.
• To highlight its importance in understanding the tumor immune microenvironment and treatment outcomes.

Main Methods:

• Review of current literature on FDG PET/CT in immuno-oncology.
• Analysis of FDG PET/CT's role in staging, response assessment, and adverse event identification.

Main Results:

• FDG PET/CT aids in assessing the tumor immune microenvironment.
• It is valuable for baseline staging and monitoring treatment response.
• It helps identify immune-related adverse events and predict immunotherapy efficacy.

Conclusions:

• A thorough understanding of FDG PET/CT applications is vital for optimizing cancer patient care, particularly in the context of immunotherapy.
• FDG PET/CT offers multidimensional insights essential for modern immuno-oncology management.